Bio-Techne Corp. Stock Underperforms Friday When Compared To Competitors

Dow Jones
2025.12.12 22:19
portai
I'm PortAI, I can summarize articles.

Bio-Techne Corp.'s stock fell 2.90% to $58.51 on Friday, underperforming compared to competitors like Amgen Inc. and BioMarin Pharmaceutical Inc. Despite a grim trading session, Bio-Techne's trading volume exceeded its 50-day average. The stock is 26.20% below its 52-week high of $79.28.